Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod.
Zoé Léonie Elise van KempenKoos Pj van DamJim B D KeijserEileen W StalmanLaura Yl KummerEva M M StrijbisMaurice SteenhuisAnja Ten BrinkeS Marieke van HamTaco KuijpersTheo RispensFilip EftimovLuuk WieskeJoep KillesteinPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Repeated SARS-CoV-2 vaccinations boost humoral immunity and, probably together with SARS-CoV-2 infections, induce humoral responses on the long-term in almost all patients.